Table 1 Baseline patient and treatment characteristics
Variables | |
|---|---|
Age (median, range) | 47 years (24–75) |
Stage | |
IB | 4 (11.4%) |
IIA | 1 (2.9%) |
IIB | 26 (74.2%) |
IIIB | 3 (8.6%) |
IVA | 1 (2.9%) |
Pathology | |
Squamous cell carcinoma | 28 (80%) |
Adenocarcinoma | 2 (5.7%) |
Adenosquamous | 5 (14.3%) |
HPV infection | |
Positive | 16 (45.7%) |
Negative | 8 (22.9%) |
No data | 11 (31.4%) |
Primary tumor size (median, range) | 4.7 (1.4–11) |
< 4 cm | 11 (31.4%) |
≥ 4 cm | 24 (68.6%) |
Initial lymph node involvement | |
Pelvic | 21 (60.0%) |
Paraaortic | 10 (28.6%) |
Negative | 8 (22.9%) |
Initial treatment | |
Definitive surgery alone | 4 (11.4%) |
Definitive CCRT | 25 (71.4%) |
Surgery + PORT | 6 (17.2%) |
PALN irradiation for initial treatment | 10 (28.6%) |
Time to PALN recurrence (median, range) | 10.0 months (2.0–50.9) |
Patterns of PALN recurrence | |
Isolated PALN recurrence | 14 (40%) |
Concurrent local recurrence | 8 (22.9%) |
Concurrent distant metastasis | 13 (37.1%) |
No. of PALN per patient (median, range) | 2 (1–12) |